Health Care & Life Sciences » Pharmaceuticals | Guangxi Liuzhou Pharmaceutical Co. Ltd.

Guangxi Liuzhou Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,540
5,647
6,497
7,532
9,412
11,683
Cost of Goods Sold (COGS) incl. D&A
4,153
5,160
5,952
6,861
8,562
10,486
Gross Income
387
487
545
671
851
1,197
SG&A Expense
161
211
242
283
339
496
EBIT
223
271
298
389
511
702
Unusual Expense
-
-
-
1
-
-
Non Operating Income/Expense
2
7
3
1
-
4
Interest Expense
40
54
37
9
22
58
Pretax Income
184
215
268
406
504
665
Income Tax
35
38
42
62
77
96
Consolidated Net Income
149
177
226
344
428
568
Net Income
149
170
208
321
401
528
Net Income After Extraordinaries
149
170
208
321
401
528
Net Income Available to Common
149
170
208
321
401
528
EPS (Basic)
0.73
1.02
1.02
1.29
1.55
2.04
Basic Shares Outstanding
205
167
205
250
259
259
EPS (Diluted)
0.73
1.02
1.02
1.29
1.55
2.04
Diluted Shares Outstanding
205
167
205
250
259
259
EBITDA
227
279
311
407
546
756
Other Operating Expense
3
4
5
1
-
-
Non-Operating Interest Income
3
3
3
26
16
17
Minority Interest Expense
-
7
18
23
26
40

About Guangxi Liuzhou Pharmaceutical Co.

View Profile
Address
No. 68 Guantang Avenue
Liuzhou Guangzi Zhuang 545000
China
Employees -
Website http://www.lzyy.cn
Updated 07/08/2019
Guangxi Liuzhou Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research & development of pharmaceutical products. It also involves in the production of general antibiotics and drugs for the digestive system. Its products include scrophularia root, cicada molting, chebule, isatis root, and sterculia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.